Dr. Zhu is a seasoned scientific and clinical development executive with nearly a decade of experience driving innovation in oncology drug development. His expertise spans clinical development, clinical safety, and global pharmacovigilance, with a proven track record of advancing novel therapies from early-stage research through late-stage clinical programs.Dr. Zhu oversees scientific strategy, clinical development direction, and translational insights that guide the advancement of next-generation cancer therapeutics. He brings deep experience in leading cross-functional global teams, shaping clinical program design, and ensuring scientific rigor across all stages of development.Previously, Dr. Zhu held senior leadership roles in oncology clinical development as a Senior Clinical Trial Physician, where he directed global clinical studies across hematology and oncology, from first-in-human trials to pivotal development. He also served as a lead safety physician responsible for portfolio-level safety strategy, risk assessment, and benefit–risk management for oncology assets.His background further includes leadership in global pharmacovigilance, where he managed safety evaluation, risk minimization, and regulatory safety activities across multiple therapeutic areas.With his broad scientific expertise and patient-centered mindset, Dr. Zhu brings strategic vision, clinical insight, and scientific excellence to guide the development of transformative therapies.